WS #7355

The dominant signal in this window is the US Supreme Court's decision to preserve mail-order access to the abortion pill mifepristone, a development corroborated by multiple major news outlets (Guardian, NBC, ABC, Reuters, Chicago Tribune) and numerous social media posts. This is a legal/political story with limited direct market impact, but it removes a near-term regulatory overhang for pharmacy and telehealth stocks. Separately, Nu Holdings (NU) reported Q1 earnings that missed EPS estimates ($0.18 vs $0.19) but beat on revenue ($4.968B vs $4.480B), with the stock getting slammed after hours. The CBRS IPO (CoreWeave) priced at $185, raising $5.55B with strong demand, signaling continued AI infrastructure appetite. CIA Director Ratcliffe's trip to Cuba and Trump's comments on US-China relations are notable but lack specific market-moving details. The House tied 212-212 on an Iran war powers resolution, indicating continued geopolitical risk. Overall, the window is dominated by the SCOTUS abortion pill ruling (high cross-source corroboration) and the NU earnings miss, with the CBRS IPO as a secondary AI theme.